Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03285321
Title Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Greg Durm, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Rush University Medical Center Chicago Illinois 60612 United States Details
University of Illinois Cancer Center Chicago Illinois 60612 United States Details
Indiana University Indianapolis Indiana 46202 United States Details
University of Louisville James Graham Brown Cancer Center Louisville Kentucky 40202 United States Details
Johns Hopkins Sidney Kimmel Comprehensive Baltimore Maryland 21287 United States Details
Karmanos Cancer Center (Wayne State University) Detroit Michigan 48201 United States Details
Michigan State University Lansing Michigan 48910 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Penn State Cancer Institute Hershey Pennsylvania 17033 United States Details
University of Wisconsin Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field